Table 2.

Demographic and clinical characteristics of study cohorts at baseline. Values are mean ± SD or n (%).

CharacteristicOntario, n = 20,918Quebec, n = 6754
Demographic
  Age at diagnosis74.9 ± 6.374.5 ± 5.9
  Female14,136 (67.6)4369 (64.7)
  Urban residence17,830 (85.2)5437 (80.5)
Clinical*
  Osteoarthritis10,676 (51.0)2549 (37.7)
  COPD/asthma**6538 (31.3)1755 (26.0)
  Diabetes**4677 (22.4)1231 (18.2)
  Coronary artery disease3737 (17.9)1571 (23.3)
  Cancer3712 (17.7)1030 (15.3)
  Extraarticular RA features3296 (15.8)1203 (17.8)
  Osteoporosis1849 (8.8)1295 (19.2)
  Acute myocardial infarction884 (4.2)243 (3.6)
  Chronic renal failure715 (3.4)257 (3.8)
  Acute renal failure540 (2.6)256 (3.8)
  Cerebrovascular disease296 (1.4)50 (0.7)
  Charlson index0.6 ± 1.31.6 ± 2.1
  Prior joint replacement2285 (10.9)328 (4.9)
  High healthcare use at baseline††3623 (17.3)2082 (30.8)
  No. rheumatology visits0.8 ± 2.00.8 ± 1.5
  • * Ascertained over the 3 years prior to baseline unless specified otherwise below.

  • ** Ascertained over all available records (1990 onwards) in Ontario, but over 3 years in Quebec.

  • Ascertained up to 10 years prior to baseline.

  • †† Defined by having at least 20 outpatient physician visits in at least 1 year of the 3 years before baseline.

  • Ascertained over the 1 year prior to baseline. COPD: chronic obstructive pulmonary disease; RA: rheumatoid arthritis.